Colistin: Clinical Trials

61 trials of Colistin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 18 unknown, 7 recruiting, 5 terminated. 22 Phase 3, 20 Phase 4, 8 Not applicable, 7 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 322Completed 9, Unknown 7, Not yet recruiting 2, Recruiting 2, Terminated 2
Phase 420Completed 7, Unknown 7, Recruiting 3, Terminated 2, Active not recruiting 1
Not applicable8Completed 5, Unknown 2, Recruiting 1
Phase 27Completed 2, Not yet recruiting 2, Unknown 2, Terminated 1
Early Phase 12Terminated 1, Unknown 1
Phase 11Completed 1

Follow Colistin: new trials by email Literature Review of Colistin trials Research Report on Colistin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
Cefepime-Zidebactam, Ceftazidime-avibactam with or without Colistin - Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)
Phase 3Not yet recruitingWockhardt3242026-10-282026-10-21
Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria
"Imipenem/cilastatin" and "Tigecycline", "colistin" and "meropenem" - MDR Bacteria
Phase 2Not yet recruitingAin Shams University602026-04-012026-04-13
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
BV100 (300 mg), Polymyxin B, Colistin - Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP)
Phase 3RecruitingBioVersys SAS2482026-03-272026-05-04
Optimising TREATment for Severe Gram-Negative Bacterial Infections
Colistin/Polymyxin B + Sulbactam, Colistin/Polymyxin B + Tigecycline/Eravacycline, Colistin/Polymyxin B + Meropenem - Bloodstream Infection, Ventilator Associated Bacterial Pneumonia
Phase 4RecruitingNational University of Singapore6002025-04-212025-06-04
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
Meropenem and Pralurbactam, Best Available Therapy (e.g., colistin, meropenem, tegecycline, amikacinceftezidime-avibatam) - Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
Phase 3RecruitingQilu Pharmaceutical Co., Ltd.802025-04-122025-07-30
Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment
colistin plus cefoperazone-sulbactam combination group, Colistin - Clinical Response, Radiological Response
Not applicableCompletedShaheed Mohtarma Benazir Bhutto Institue of Trauma802025-02-012026-06-26
Therapeutic Options for CRAB
Fosfomycin, Eravacycline, ampicillin/sulbactam - Infections, Bacterial, Sepsis Bacterial
Phase 4RecruitingClinical Hospital Centre Zagreb1082025-01-302026-01-21
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
Colistimethate Sodium, Tigecycline - Infection in ICU
Phase 4Active not recruitingBeni-Suef University1322024-12-012025-03-25
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Cefiderocol, Ampicillin-sulbactam, Colistin - Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia
Phase 4RecruitingRambam Health Care Campus7342024-09-012025-08-01
Colistin Dosage Prsonalization Approach
Polymyxin e - Colistin Adverse Reaction
RecruitingMahmoud I Mostafa1002024-07-302025-08-13
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
treatment with or without colistin - Carbapenem-Resistant Enterobacteriaceae Infection
Not applicableRecruitingSoutheast University, China4042023-11-272025-05-18
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
Colistin Sodium Methanesulfonate, Colistin Sodium Methanesulfonate plus Fosfomycin - Infection Due to Carbapenem Resistant Acinetobacter
Phase 4UnknownChiang Mai University1882023-04-012024-08-26
Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
Colistin, Minocycline, Placebo - Acinetobacter Infections
Phase 4UnknownMahidol University942023-01-102023-01-18
The Effect of Curcumin Against Colistin-induced Nephrotoxicity
Colistin, Curcumin - Acute Kidney Injury, Drug-Induced Nephropathy
Phase 3UnknownOctober 6 University2142023-01-012023-10-31
Pharmacokinetics of Colistin in Critically Ill Patients With Extracorporeal Membrane Oxygenation
Colistin - Colistin
Phase 4TerminatedSt. Anne's University Hospital Brno, Czech Republic82022-09-012024-01-31
Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections
Ceftazidime-avibactam, Colistin - Carbapenem-Resistant Enterobacteriaceae Infection
Phase 3TerminatedKing Faisal Specialist Hospital & Research Center292022-06-012024-06-14
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
lactulose, colistin - Hepatic Encephalopathy
Early Phase 1UnknownMadonna Magdy Fahmy3162022-03-012022-03-15
Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED
Colistin Sulfomethate - Bacterial Infections
Phase 4CompletedMahidol University132021-10-182022-11-28
Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
Colistin - Secondary Bacterial Infection in COVID-19 Patients
Phase 3CompletedBeni-Suef University1282021-08-032023-01-19

Showing 20 of 61. Sign in to see all of them.

Conditions studied

Pneumonia, Ventilator-Associated (10)  ·  Sepsis (8)  ·  Pneumonia (6)  ·  Critical Illness (5)  ·  Acinetobacter Infections (4)  ·  Bacterial Infections (3)  ·  Cystic Fibrosis (3)  ·  Gram-Negative Bacterial Infections (3)  ·  Infections (3)  ·  Bacteremia (2)  ·  Cross Infection (2)  ·  Healthcare-Associated Pneumonia (2)  ·  Neoplasms (2)  ·  Acute Kidney Injury (1)  ·  Anastomotic Leak (1)

Sponsors

Mahidol University (6)  ·  Rambam Health Care Campus (3)  ·  Beni-Suef University (2)  ·  University of Thessaly (2)  ·  Achaogen, Inc. (1)  ·  Ain Shams University (1)  ·  Al-Azhar University (1)  ·  BioVersys SAS (1)  ·  Chiang Mai University (1)  ·  Clinical Hospital Centre Zagreb (1)  ·  DongGuk University (1)  ·  Entasis Therapeutics (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Gangnam Severance Hospital (1)

Countries

Thailand (10)  ·  Egypt (8)  ·  Israel (8)  ·  Greece (7)  ·  Italy (5)  ·  United States (5)  ·  China (4)  ·  Spain (4)  ·  France (3)  ·  India (3)  ·  Saudi Arabia (3)  ·  Australia (2)  ·  Belarus (2)  ·  Bulgaria (2)  ·  Croatia (2)

Top investigators

Visanu Thamlikitkul, MD (3)  ·  Adhiratha Boonyasiri, MD (2)  ·  Ahlem Trifi (1)  ·  Ahmed F Mady, PhD (1)  ·  Ami Neuberger, Dr (1)  ·  Anthony Gordon, MD FRCA (1)  ·  Athitaya Luangnara (1)  ·  Ayelet Raz, Dr (1)  ·  Brian Cuthbertson, MD FRCA (1)  ·  Dafna Yahav (1)  ·  David Seligson, MD (1)  ·  Eyal Braun, Dr (1)  ·  H.J. Bonjer, Md, PhD, FRCSC (1)

Results publications

PMID 29456043, PMID 15276398, PMID 15561858, PMID 15840453, PMID 15865552, PMID 19588358, PMID 21129208, PMID 22530208, PMID 23352693, PMID 23616495, PMID 23636182, PMID 24207137, PMID 24814583, PMID 24982065, PMID 25801556, PMID 25872790, PMID 27033711, PMID 27098822, PMID 28575278, PMID 28970161, PMID 29755707, PMID 30462182, PMID 30476654, PMID 30478168, PMID 30616014, PMID 30802304, PMID 31220256, PMID 31254273, PMID 31779711, PMID 31954100, PMID 33789574, PMID 34775134, PMID 36286097, PMID 37182534, PMID 37518089, PMID 37538951, PMID 37982826, PMID 38045525, PMID 39340688, PMID 40669898, PMID 41159880, PMID 41194117, PMID 42642777, PMID 4902833, PMID 8948280

NIH funding

2014 (1)